Russian Sputnik V vaccines showed 80 percent efficacy against the coronavirus disease (COVID-19) six to eight months after the second dosage, the Russian Direct Investment Fund (RDIF) announced in a global press conference on Wednesday, Nov. 24. During a joint press conference with the Gamaleya National Research Center of Epidemiology ...

Source: Manila Bulletin (https://mb.com.ph/2021/11/26/russian-team-presents-data-showing-sputnik-vs-long-term-efficacy/?utm_source=rss&utm_medium=rss&utm_campaign=russian-team-presents-data-showing-sputnik-vs-long-term-efficacy)